GLYTHERIX LTD
Who is GLYTHERIX LTD?
GlyTherix Ltd, is a targeted radiotherapy company with a clinical stage antibody product, Miltuximab®, showing an excellent safety profile in high unmet need cancers. Miltuximab® specifically targets GPC-1, a protein found on solid tumours such as prostate, bladder, pancreatic, glioblastoma, oesopha...See more
Industry & Specialities
Others
Countries of Operation
Australia
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2017 (9 years)
Address:
3 INNOVATION RD; LEVEL 1; MACQUARIE PARK, NEW SOUTH WALES 2113, AU
Employees by Department
- The Rest (5)
- Total (5)
Key Decision Makers
Brad Walsh
CEO
Doug Campbell
Head Of Research And Development
Angela Jiehua Wu
Research Scientist
Yanling Lu
Head of CMC (Chemistry, Manufacturing and Controls)
Employees by Seniority
C-level
1employees
Senior
0employees
Non-managers
1employees
Financials
LOW
spending power
Funding Status
Private
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has GLYTHERIX LTD been operating for?
- What is the funding status of GLYTHERIX LTD?
- Where is GLYTHERIX LTD's headquarter?
- What GLYTHERIX LTD's spending power?
- Does GLYTHERIX LTD have a presence in the domain it operates in?